Itron (NASDAQ:ITRI) Given New $110.00 Price Target at Stephens

Itron (NASDAQ:ITRI) had its target price boosted by equities research analysts at Stephens from $85.00 to $110.00 in a research report issued on Monday, Benzinga reports. The brokerage presently has an “equal weight” rating on the scientific and technical instruments company’s stock. Stephens’ target price would suggest a potential upside of 3.02% from the company’s previous close.

Several other research firms have also weighed in on ITRI. Robert W. Baird raised their target price on Itron from $108.00 to $115.00 and gave the company an “outperform” rating in a report on Wednesday, March 13th. TheStreet upgraded shares of Itron from a “c” rating to a “b-” rating in a research report on Monday, February 26th. Canaccord Genuity Group upped their target price on shares of Itron from $105.00 to $115.00 and gave the stock a “buy” rating in a research note on Friday. TD Cowen lifted their price target on Itron from $110.00 to $115.00 and gave the stock a “buy” rating in a report on Friday. Finally, Oppenheimer lifted their price target on shares of Itron from $100.00 to $110.00 and gave the company an “outperform” rating in a research report on Friday. Four analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $104.18.

Itron Trading Down 0.2 %

Itron stock traded down $0.23 during trading on Monday, hitting $106.78. The company’s stock had a trading volume of 93,266 shares, compared to its average volume of 431,440. The stock has a market capitalization of $4.90 billion, a price-to-earnings ratio of 30.77, a P/E/G ratio of 1.16 and a beta of 1.38. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.40 and a current ratio of 1.90. The stock’s fifty day moving average is $91.94 and its 200 day moving average is $77.64. Itron has a 1-year low of $56.11 and a 1-year high of $108.60.

Itron (NASDAQ:ITRI) last released its earnings results on Thursday, May 2nd. The scientific and technical instruments company reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $0.39. Itron had a return on equity of 14.51% and a net margin of 7.03%. The company had revenue of $603.44 million for the quarter, compared to the consensus estimate of $579.49 million. During the same quarter last year, the business posted $0.49 EPS. Itron’s quarterly revenue was up 22.0% compared to the same quarter last year. As a group, equities research analysts predict that Itron will post 3.68 EPS for the current year.

Insider Buying and Selling at Itron

In related news, CEO Thomas Deitrich sold 1,912 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $75.37, for a total value of $144,107.44. Following the transaction, the chief executive officer now directly owns 169,073 shares of the company’s stock, valued at approximately $12,743,032.01. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, CEO Thomas Deitrich sold 1,912 shares of Itron stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $75.37, for a total value of $144,107.44. Following the completion of the sale, the chief executive officer now owns 169,073 shares in the company, valued at approximately $12,743,032.01. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Joan S. Hooper sold 1,560 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $75.37, for a total transaction of $117,577.20. Following the completion of the transaction, the chief financial officer now owns 60,141 shares of the company’s stock, valued at approximately $4,532,827.17. The disclosure for this sale can be found here. Over the last three months, insiders have sold 30,467 shares of company stock valued at $2,752,520. 1.45% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in ITRI. Contravisory Investment Management Inc. lifted its stake in shares of Itron by 61.5% during the first quarter. Contravisory Investment Management Inc. now owns 344 shares of the scientific and technical instruments company’s stock valued at $32,000 after buying an additional 131 shares during the period. GAMMA Investing LLC acquired a new position in Itron during the 4th quarter worth $27,000. Covestor Ltd lifted its position in shares of Itron by 9,150.0% in the 3rd quarter. Covestor Ltd now owns 555 shares of the scientific and technical instruments company’s stock worth $34,000 after buying an additional 549 shares during the last quarter. Harvest Fund Management Co. Ltd bought a new stake in Itron in the 4th quarter valued at about $50,000. Finally, C M Bidwell & Associates Ltd. bought a new stake in Itron in the 4th quarter valued at about $76,000. 96.19% of the stock is currently owned by institutional investors and hedge funds.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.